Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent

Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent

US Patent 5676978 · Granted Oct 14, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)2025
Polymeric nanoparticles providing nucleic acids encoding TNF-α2022
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)2021
Modulating the aryl hydrocarbon receptor system to treat major depressive disord2021
Compositions and methods of treating cancer2021
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)2020
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)2018
Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer the2017
Compositions and methods for treating cancer2017
Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemot2017
MUC-1 cytoplasmic domain peptides as inhibitors of cancer2017
Inhibition of inflammation using antagonists of MUC12015